Fox Chase Cancer Center News

IGF-1R a Marker for, but Not Driving Wild-Type GIST

PHILADELPHIA (February 3, 2020) – Although insulin-like growth factor receptor-1 (IGF-R1) is a biomarker for wild-type gastrointestinal stromal tumors (GIST), these mutations do not appear to be driving the disease, according to the results of a study from researchers at Fox Chase Cancer Center.

VIEW STORY

Fox Chase Cancer Center Welcomes Claudia J. Kasales

PHILADELPHIA (January 20, 2020) – Claudia J. Kasales, MD, MHA, FACR, who will be joining the Department of Diagnostic Imaging as a professor on the academic clinician track. She will begin work at Fox Chase on February 1, 2020.

VIEW STORY